Solid Tumors Clinical Trials in Grand Rapids, Michigan

7 studies are recruiting for solid tumors in Grand Rapids, Michigan right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. REC-7735 in Participants With Solid Tumors

    The study is designed to characterize the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD), and preliminary anti-tumor activity of REC-7735 in participants with unresectable, locally advanced, or metastatic PIK3CA-H1047R mutated solid tumors.

    Stage
    Phase 1
    Ages
    18 and older
    Site
    START Midwest, Grand Rapids, Michigan
    Locations
    3 in total
    Run by
    Recursion Pharmaceuticals Inc.

    See if you can join NCT07819136 on ClinicalTrials.gov

  2. A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma

    The purpose of this study is to evaluate the efficacy and safety of standard chemotherapy with or without INCB161734 in participants with metastatic pancreatic ductal adenocarcinoma (PDAC).

    Stage
    Phase 3
    Ages
    18 and older
    Site
    Investigative Site US078, Grand Rapids, Michigan
    Locations
    229 in total
    Run by
    Incyte Corporation

    See if you can join NCT07522073 on ClinicalTrials.gov

  3. A Study to Evaluate the Safety of INCA33890 in Participants With Advanced or Metastatic Solid Tumors

    To evaluate the safety, tolerability, and DLTs and determine the MTD and/or RDE(s) of INCA33890 in participants with select advanced or metastatic solid tumors.

    Stage
    Phase 1
    Ages
    18 and older
    Site
    Cancer and Hematology Centers of Western Michigan-Start Midwest, Grand Rapids, Michigan
    Locations
    39 in total
    Run by
    Incyte Corporation

    See if you can join NCT05836324 on ClinicalTrials.gov

  4. Study of AUBE00 in Patients With Solid Tumors

    This is a first-in-human, Phase I, open-label, multicenter, multinational study, designed to evaluate the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD), immunogenicity, and anti-tumor activity of AUBE00 in patients with locally advanced or metastatic solid tumors.The total numb…

    Stage
    Phase 1
    Ages
    18 and older
    Site
    South Texas Accelerated Research Therapeutics (START) Midwest, Grand Rapids, Michigan
    Locations
    4 in total
    Run by
    Chugai Pharmaceutical

    See if you can join NCT07030959 on ClinicalTrials.gov

  5. A Study to Evaluate the Safety,Tolerability, Pharmacokinetics and Clinical Activity of Mocertatug Rezetecan for Injection in Participants With Advanced Solid Tumors (BEHOLD-1)

    The goal of this study is to assess the safety and tolerability of Mocertatug Rezetecan . The study will also see how the levels of Mo-Rez change over time at different dose amount

    Stage
    Phase 1
    Ages
    18 and older
    Site
    GSK Investigational Site, Grand Rapids, Michigan
    Locations
    65 in total
    Run by
    GlaxoSmithKline

    See if you can join NCT06431594 on ClinicalTrials.gov

  6. A Study of XB371 Administered in Participants With Locally Advanced or Metastatic Solid Tumors

    The primary purpose of the study is to characterize the safety and tolerability of XB371. The dose-escalation cohorts and Part B of the expansion cohorts are non-randomized. Part A of the expansion cohorts is randomized.

    Stage
    Phase 1
    Ages
    18 and older
    Site
    Exelixis Clinical Site #3, Grand Rapids, Michigan
    Locations
    9 in total
    Run by
    Exelixis

    See if you can join NCT07123103 on ClinicalTrials.gov

  7. A Study of ADRX-0405 in Subjects With Select Advanced Solid Tumors

    The primary purpose of this study is to assess the safety, tolerability, and pharmacokinetics, and to identify the optimal dose of ADRX-0405 in patients with select advanced solid tumors.

    Stage
    Phase 1
    Ages
    18 and older
    Site
    START Midwest, Grand Rapids, Michigan
    Locations
    8 in total
    Run by
    Adcentrx Therapeutics

    See if you can join NCT06710379 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.